MuSK-CAART
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MuSK-CAART, covering 2025-11-10 to 2025-11-10. Get the full timeline:
Most recent: Clinical Trial Update: Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis [Phase 1]